stockrow
Friday 6 November 2026
Export FOCL’s income statement to Excel — free account
FocalTherics
FOCL Healthcare Medical Distribution
- Revenue
- +38.9%
- EPS
- −129.4%
- Free cash flow
- +21.5%
- Total debt
- +366.8%
Quarter to June 2026, against a year earlier
3.66
0.59
−13.88%
Follow FOCL
Alert me
FocalTherics (FOCL) P/E ratio
FocalTherics has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 1,771× (May 2022) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 248× | — |
| FY2020 | 0.0× | — |
| FY2019 | 84.7× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 20.9× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 1,771×
Ten-year median
0.0×
Current reading's percentile
66
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| ACH Accendra Health, Inc. compare | n/m |
| FOCL FocalTherics | n/m |
| MEDS DataMeds AI, Inc compare | n/m |
| YI 111, Inc. Sponsored ADR compare | n/m |
| AHG Akso Health Group Sponsored ADR compare | n/m |
| SNYRQ Synergy CHC Corp. compare | n/m |
| COSM Cosmos Health Inc. compare | n/m |
| HSIC Henry Schein, Inc. compare | 22.8× |
| HKPD Cellyan Biotechnology Co., Ltd compare | — |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)